Trademarkia Logo

Canada

C$
Trademark Search in Canada
HEXAGON VERTICAL CHAIN DESIGN
HEXAGON VERTICAL CHAIN DESIGN
CANCELLED

Last Applicant/ Owned by

CytoDyn Inc.

Suite 660, 1111 Main StreetVancouver WA 98660

US

Serial Number

2066973 filed on 6th Oct 2020

Registration Number

TMA1135063 registered on 20th Jul 2022

Registration expiry Date

6th Oct 2030

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

HEXAGON VERTICAL CHAIN DESIGN

Trademark usage description

therapeutic preparations, namely, antibodies for use in targeting the ccr5 cell receptor, for preventing and/or treating hiv, cancer, graft-versus-hos Read More

Vienna Information


1 . 13 . 1

Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 15

Atomic models, molecular models, representations of human, animal or vegetal cells, images of bacteria or viruses, DNA helixesSchémas atomiques, schémas de molécules, représentations de cellules humaines, animales ou végétales, images de bactéries ou de virus, hélices d'ADN

26 . 5 . 2

Two polygons, one inside the other (except 26.5.10 and 26.5.11)Deux polygones, l'un dans l'autre (excepté 26.5.10 et 26.5.11)

26 . 5 . 4

Several polygons, juxtaposed, joined or intersectingPlusieurs polygones, juxtaposés, accolés ou se coupant

26 . 5 . 13

Polygons containing representations of heavenly bodies or natural phenomenaPolygones contenant la représentation de corps célestes ou de phénomènes naturels

26 . 5 . 26

Polygons with cutout areasPolygones avec des zones découpées

Classification Information


Class [005]
Therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor, for preventing and/or treating HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, respiratory diseases and disorders; therapeutic preparations for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, respiratory diseases and disorders; therapeutic preparations for the treatment of COVID-19.


Classification kind code

11

Mark Details


Serial Number

2066973

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 27
on 31st Mar 2022
Approval Notice Sent
Submitted for opposition 26
on 31st Mar 2022
Approved
Submitted for opposition 22
on 25th Mar 2022
Search Recorded
Submitted for opposition 256
on 27th Sept 2021
Notification of Possible Opposition Sent
Submitted for opposition 48
on 22nd Jun 2021
Agent Changed
Submitted for opposition 31
on 30th Nov 2020
Formalized
Submitted for opposition 1
on 30th Nov 2020
Created
Submitted for opposition 257
on 26th Nov 2020
Designation Notification - Madrid Protocol
Submitted for opposition 228
on 6th Oct 2020
International Registration
Submitted for opposition 30
on 6th Oct 2020
Filed